Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences High-Content and Phenotypic Screening Europe 2018

Hua Rong Lu's Biography



Hua Rong Lu, Senior Principal Scientist, Discovery Sciences, Janssen Pharmaceutical NV

Hua Rong Lu obtained an MD in China and PhD (Katholieke University Leuven) and has more 25 years pharmaceutical research experience in drug discovery and cardiac safety/translational research. He has more than 60 full papers published in international journals.

Hua Rong Lu Image

Human Stem Cell Research for Potential Drug-induced Cardiac and Neuronal Side Effects

Thursday, 24 May 2018 at 14:00

Add to Calendar ▼2018-05-24 14:00:002018-05-24 15:00:00Europe/LondonHuman Stem Cell Research for Potential Drug-induced Cardiac and Neuronal Side EffectsHigh-Content and Phenotypic Screening Europe 2018 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com

Human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs) and HiPS-neurons are increasingly used as a new source of human based-cells for drug safety assessment.  Indeed attention to this field may increase in response to the FDA’s CiPA proposal for long QT and pro-arrhythmias and HESI-MEA for drug-induced seizures. Within Janssen, we are currently investigating the effects of different reference compounds in different types of hiPS-CMs and hiPS-neurons using different high content screen assays, and establishing potential assay (s) using HiPS-cells for early drug discovery and development.


Add to Calendar ▼2018-05-24 00:00:002018-05-25 00:00:00Europe/LondonHigh-Content and Phenotypic Screening Europe 2018High-Content and Phenotypic Screening Europe 2018 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com